Building on the success of Investing in Medical Nanotechnologies I, this event promises a display of state-of-the-art medical nanotechnologies and routes to finance. The associated exhibition will showcase cutting edge nanotechnologies in clinical applications.
The event will provide a platform for new companies trying to commercialize nano and micro technologies to get in front of investors. The investors and business support organisations will be able to identify the key technologies of future as well as new customers. Investing in Medical Nanotechnologies -2006 attracted a huge number of companies including large corporations (Philips, Siemens, GE, GlaxoSmithKline, Johnson & Johnson, BASF etc.), small companies, investors, academics, patent and trademark attorneys and other stakeholders. It was an excellent event which gave an insight into the latest technological developments in the area and provided fabulous networking opportunities for the stakeholders.
To know more about last conference and the list of major companies attended, visit: www.nanomednet.org/conference
Poster Exhibition Opportunities:
An opportunity for all delegates to showcase their Research & Development to potential partners, investors and customers. To apply, send a short abstract (no more than 300 words) to Tiju Joseph, (email tiju.joseph@nano.org.uk). All delegates whose abstracts are accepted will get a chance to exhibit their posters. This service is complimentary to the conference delegates.
Be the first one to learn the technology trends and market opportunities in nanomedicine.
- Learn from top industrial leaders on how nanotech drives new technology applications in medicine.
- Hear from VCs about the best investing strategies and overcoming challenges.
- Find out about new technologies for medical applications.
- Hear from clinicians on how nanotechnology enables new diagnostics and therapeutic techniques.
- Participate in discussions with experts in the field.
- Meet exhibitors at the cutting edge of medical nanotechnology
Speakers include:
- Prof. Dr. J.W. Hans Hofstraat, Vice President, Healthcare Strategic Partnerships,
Philips Research - Dr Thomas Keller, Director - Worldwide Applied Technology, GlaxoSmithKline
- Mr.Michael Lussier, MD, Volcano Corporation
- Prof. Jörg Vienken, Vice-President BioScience Department, Fresenius Medical Care
- Robert Jelski, Sector Partner, Electronics, Semiconductors & Advanced Technologies, 3i
- Dr. Renzo Tomellini, Head of Nanotechnology Unit, European Commission
- Prof. Amarnath Maitra,
- Prof. Seeram Ramakrishna, Dean of the Faculty of Engineering,
Conference themes include:
- The Promise of Nanomedicine
- Tissue Engineering and Regenerative Medicine
- Drug Delivery and Pharmaceutical Development
- Clinical Applications of Nanotechnology
- Novel Devices, Nanosensors and Diagnostics
- Investing in Nanomedicine: Strategy and Vision for the Future
| 2006 attendees included:
| Companies that attended included:
And many small companies… |
No comments:
Post a Comment